Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Collieva** is a collagen-based medical device developed by Innocoll, a specialty pharmaceutical company specializing in biocompatible, biodegradable collagen products for wound care and surgical applications. It is manufactured using Type 1 collagen at Innocoll's facility in Saal, Germany, and has received regulatory clearance, including FDA 510(k) clearance as a collagen sponge substantially equivalent to products like CollaGUARD. Primarily indicated for advanced wound care, it leverages collagen's natural properties to support tissue repair and healing in surgical or wound sites, and is commercialized through strategic partnerships.[4][6][8][12]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Collieva.